Skip to content
DataLookout
Start free
Menu

NCT07907666

Ropivacaine Alone Versus Ropivacaine Plus Lidocaine With or Without Epinephrine for Supraclavicular Brachial Plexus Block in Upper Limb Orthopedic Surgery

StatusCompleted
PhasePhase 4
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Postoperative Pain Intensity at 6 Hours
Timeframe: 6 hours after the end of surgery

Secondary (6)

Postoperative Pain Intensity at 0 and 12 Hours
Number of Participants Requiring Rescue Analgesia (Duration of Analgesia)
Rescue Analgesic Consumption by Drug Type
Number of Participants Receiving Postoperative Opioids
Upper Limb Motor Block (Modified Bromage Scale)
Show 1 moreShow less
Number of Participants With Block-Related Adverse Events

Arms and interventions

Group C: Ropivacaine 0.375%Active comparator

Ultrasound-guided supraclavicular brachial plexus block with 30 mL of ropivacaine 0.375% (15 mL of ropivacaine 0.75% plus 15 mL of sterile water for injection), single perineural injection.

Group L: Ropivacaine 0.375% + Lidocaine 1%Experimental

Ultrasound-guided supraclavicular brachial plexus block with 30 mL of ropivacaine 0.375% plus lidocaine 1% (15 mL of ropivacaine 0.75% plus 15 mL of lidocaine 2%), single perineural injection.

Group E: Ropivacaine 0.375% + Lidocaine 1% With EpinephrineExperimental

Ultrasound-guided supraclavicular brachial plexus block with 30 mL of ropivacaine 0.375% plus lidocaine 1% with epinephrine (15 mL of ropivacaine 0.75% plus 15 mL of lidocaine 2% with epinephrine; final epinephrine concentration 2.5 micrograms/mL, 75 micrograms total), single perineural injection.

Drugs: ropivacaine, lidocaine, lidocaine with epinephrine

Sites

1 site in 1 country

  • Hospital General de Zona No. 3, Instituto Mexicano del Seguro SocialAguascalientes, Aguascalientes, Mexico